Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand.

CONCLUSIONS: The survival for patients with MBC in New Zealand is very similar to other developed countries. Patients with dnMBC had a much better prognosis than those with recurrent disease. Patients with triple negative disease or non-luminal HER2 positive disease had the worst prognosis. The prognosis for patient with rMBC improved the longer the time from diagnosis to the development of metastases.
PMID: 33044617 [PubMed - as supplied by publisher]

Source: Breast Cancer - October 12, 2020 Category: Cancer & Oncology Authors: Lao C, Kuper-Hommel M, Elwood M, Campbell I, Edwards M, Lawrenson R Tags: Breast Cancer Source Type: research